Peginterferon alfa-2b is an injectable medication used for treating chronic (long term) hepatitis C (Pegintron). It's also used to prevent melanoma, or skin cancer, (Sylatron) from coming back after surgery. Both brands have been discontinued and are no longer available in the United States.
Peginterferon alfa-2b is a biologic that activates your body's natural immune system to fight off the hepatitis C virus. The way it works to prevent melanoma from coming back after surgery (Sylatron) isn't fully known.
No, peginterferon alfa-2b has been discontinued and is no longer available in the United States.
The manufacturer voluntarily discontinued peginterferon alfa-2b for business reasons. It wasn't taken off the market for safety concerns.
Pegintron and Sylatron both contain man-made forms of interferon alfa-2b which are injected under the skin. The main difference is that Pegintron is used to treat people with long-term hepatitis C, and Sylatron is used to prevent melanoma from coming back after surgery. The amount of medication used and how often it's used is different depending on the condition you're treating.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.
Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.